Systemic oxygen tension (PO2) (PO2)

Systemic oxygen tension refers to the partial pressure of oxygen (PO2) in the blood, representing the amount of oxygen available for tissue perfusion and cellular metabolism (StatPearls, 2023). It is a critical physiological variable rather than a single molecular entity, though its regulation is governed by a sophisticated molecular sensing apparatus known as the Hypoxia-Inducible Factor (HIF) pathway (Nature Reviews Nephrology, 2020). The primary molecular sensors are prolyl hydroxylase domain (PHD) enzymes, which utilize molecular oxygen as a co-substrate to mark HIF-alpha subunits for proteasomal degradation under normoxic conditions. When systemic oxygen tension falls (hypoxia), PHD activity decreases, allowing HIF to stabilize and initiate the transcription of genes for erythropoiesis and angiogenesis. Pharmacological agents such as HIF prolyl hydroxylase inhibitors (HIF-PHIs) target this sensing mechanism to treat anemia by simulating a state of low oxygen tension, while supplemental oxygen therapy is used to directly elevate systemic levels in clinical settings (NEJM, 2021). Monitoring systemic oxygen tension is vital in managing respiratory failure, cardiovascular disease, and chronic kidney disease-associated anemia.

Other names

Partial pressure of oxygenArterial oxygen tensionPaO2Blood oxygen tensionOxygen partial pressure

Direct supplementation of molecular oxygen to increase dissolved gas levels or pharmacological inhibition of HIF prolyl hydroxylases to stabilize hypoxia-inducible factors and stimulate endogenous erythropoietin production.